Naomi W. Lucchi

Naomi W. Lucchi

Auto-generated profile, based on publicly available information

Naomi W. Lucchi

U.S. President’s Malaria Initiative, U.S. Centers for Disease Control and Prevention, Kigali, Rwanda

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
AUAline Uwimana
Aline Uwimana
NUNoella Umulisa
Noella Umulisa
MVMeera Venkatesan
Meera Venkatesan
SSSamaly S Svigel
Samaly S Svigel
ZZZhiyong Zhou
Zhiyong Zhou
NLNaomi W Lucchi
Naomi W Lucchi

29 October 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NLNaomi W. Lucchi
Naomi W. Lucchi
ADAllison Demas
Allison Demas
JNJothikumar Narayanan
Jothikumar Narayanan
DSDeborah Sumari
Deborah Sumari
AKAbdunoor Kabanywanyi
Abdunoor Kabanywanyi
VUVenkatachalam Udhayakumar
Venkatachalam Udhayakumar
Molecular diagnostic methods can complement existing tools to improve the diagnosis of malaria. However, they require good laboratory infrastructure thereby restricting their use to reference laboratories and research studies. Therefore, adopting molecular tools for routine use in malaria endemic countries will require simpler molecular platforms. The recently developed loop-mediated isothermal amplification (LAMP) method is relatively simple and can be improved for better use in endemic countries. In this study, we attempted to improve this method for malaria diagnosis by using a simple and portable device capable of performing both the amplification and detection (by fluorescence) of LAMP in one platform. We refer to this as the RealAmp method. Published genus-specific primers were used to test the utility of this method. DNA derived from different species of malaria parasites was used for the initial characterization. Clinical samples of P. falciparum were used to determine the sensitivity and specificity of this system compared to microscopy and a nested PCR method. Additionally, directly boiled parasite preparations were compared with a conventional DNA isolation method. The RealAmp method was found to be simple and allowed real-time detection of DNA amplification. The time to amplification varied but was generally less than 60 minutes. All human-infecting Plasmodium species were detected. The sensitivity and specificity of RealAmp in detecting P. falciparum was 96.7% and 91.7% respectively, compared to microscopy and 98.9% and 100% respectively, compared to a standard nested PCR method. In addition, this method consistently detected P. falciparum from directly boiled blood samples. This RealAmp method has great potential as a field usable molecular tool for diagnosis of malaria. This tool can provide an alternative to conventional PCR based diagnostic methods for field use in clinical and operational programs.

29 March 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
HSHannah C. Slater
Hannah C. Slater
ARAmanda Ross
Amanda Ross
IFIngrid Felger
Ingrid Felger
NHNatalie E. Hofmann
Natalie E. Hofmann
LRLeanne Robinson
Leanne Robinson
LOLucy C Okell
Lucy C Okell
Malaria infections occurring below the limit of detection of standard diagnostics are common in all endemic settings. However, key questions remain surrounding their contribution to sustaining transmission and whether they need to be detected and targeted to achieve malaria elimination. In this study we analyse a range of malaria datasets to quantify the density, detectability, course of infection and infectiousness of subpatent infections. Asymptomatically infected individuals have lower parasite densities on average in low transmission settings compared to individuals in higher transmission settings. In cohort studies, subpatent infections are found to be predictive of future periods of patent infection and in membrane feeding studies, individuals infected with subpatent asexual parasite densities are found to be approximately a third as infectious to mosquitoes as individuals with patent (asexual parasite) infection. These results indicate that subpatent infections contribute to the infectious reservoir, may be long lasting, and require more sensitive diagnostics to detect them in lower transmission settings.

12 May 2020 in eLife
Verified
Journal Article
Open access
LMLuana C Mathieu
Luana C Mathieu
HCHorace Cox
Horace Cox
AEAngela M Early
Angela M Early
SMSachel Mok
Sachel Mok
YLYassamine Lazrek
Yassamine Lazrek
LMLise Musset
Lise Musset
Antimalarial drug resistance has historically arisen through convergent de novo mutations in Plasmodium falciparum parasite populations in Southeast Asia and South America. For the past decade in Southeast Asia, artemisinins, the core component of first-line antimalarial therapies, have experienced delayed parasite clearance associated with several pfk13 mutations, primarily C580Y. We report that mutant pfk13 has emerged independently in Guyana, with genome analysis indicating an evolutionary origin distinct from Southeast Asia. Pfk13 C580Y parasites were observed in 1.6% (14/854) of samples collected in Guyana in 2016–2017. Introducing pfk13 C580Y or R539T mutations by gene editing into local parasites conferred high levels of in vitro artemisinin resistance. In vitro growth competition assays revealed a fitness cost associated with these pfk13 variants, potentially explaining why these resistance alleles have not increased in frequency more quickly in South America. These data place local malaria control efforts at risk in the Guiana Shield.

20 February 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NLNaomi W. Lucchi
Naomi W. Lucchi
JNJothikumar Narayanan
Jothikumar Narayanan
MKMara A. Karell
Mara A. Karell
MXManiphet Xayavong
Maniphet Xayavong
SKSimon Kariuki
Simon Kariuki
VUVenkatachalam Udhayakumar
Venkatachalam Udhayakumar
There is a critical need for developing new malaria diagnostic tools that are sensitive, cost effective and capable of performing large scale diagnosis. The real-time PCR methods are particularly robust for large scale screening and they can be used in malaria control and elimination programs. We have designed novel self-quenching photo-induced electron transfer (PET) fluorogenic primers for the detection of P. falciparum and the Plasmodium genus by real-time PCR. A total of 119 samples consisting of different malaria species and mixed infections were used to test the utility of the novel PET-PCR primers in the diagnosis of clinical samples. The sensitivity and specificity were calculated using a nested PCR as the gold standard and the novel primer sets demonstrated 100% sensitivity and specificity. The limits of detection for P. falciparum was shown to be 3.2 parasites/µl using both Plasmodium genus and P. falciparum-specific primers and 5.8 parasites/µl for P. ovale, 3.5 parasites/µl for P. malariae and 5 parasites/µl for P. vivax using the genus specific primer set. Moreover, the reaction can be duplexed to detect both Plasmodium spp. and P. falciparum in a single reaction. The PET-PCR assay does not require internal probes or intercalating dyes which makes it convenient to use and less expensive than other real-time PCR diagnostic formats. Further validation of this technique in the field will help to assess its utility for large scale screening in malaria control and elimination programs.

21 December 2015 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
SCStella Maris Chenet
Stella Maris Chenet
SOSheila Akinyi Okoth
Sheila Akinyi Okoth
CHCurtis S. Huber
Curtis S. Huber
JCJavin Chandrabose
Javin Chandrabose
NLNaomi W. Lucchi
Naomi W. Lucchi
VUVenkatachalam Udhayakumar
Venkatachalam Udhayakumar
Suspected artemisinin resistance in Plasmodium falciparum can be explored by examining polymorphisms in the Kelch (PfK13) propeller domain. Sequencing of PfK13 and other gene resistance markers was performed on 98 samples from Guyana. Five of these samples carried the C580Y allele in the PfK13 propeller domain, with flanking microsatellite profiles different from those observed in Southeast Asia. These molecular data demonstrate independent emergence of the C580Y K13 mutant allele in Guyana, where resistance alleles to previously used drugs are fixed. Therefore, in Guyana and neighboring countries, continued molecular surveillance and periodic assessment of the therapeutic efficacy of artemisinin-based combination therapy are warranted.